R. Hu

Comprehensive Analysis of EGFR‐Mutant Abundance and Its Effect on Efficacy of EGFR TKIs in Advanced NSCLC with EGFR Mutations

F. Hirsch, Guohua Yang, S. Ren, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

B. Liao, Qiang Li, Z. Tu, 2021, Frontiers in Oncology.

A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in Nasopharyngeal Carcinoma Based on a Risk Score Model

Z. Tu, Dan Gong, L. Zeng, 2022, Oncology Research and Treatment.

Nimotuzumab plus induction chemotherapy followed by radiotherapy/concurrent chemoradiotherapy plus nimotuzumab for locally advanced nasopharyngeal carcinoma: protocol of a multicentre, open-label, single-arm, prospective phase II trial

Yan Liu, Zhiping Lu, Dan Gong, 2022, BMJ Open.

Folate Receptor – Positive Circulating Tumor Cells as a Novel Diagnostic Biomarker in Non – Small Cell Lung Cancer 1

Yibo Gao, Zhaoli Chen, Jiagen Li, 2013 .

Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer.

Yibo Gao, Zhaoli Chen, Jiagen Li, 2013, Translational oncology.